Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1997;28:1115-1122

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joshi, S.
Right arrow Articles by Jackson, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joshi, S.
Right arrow Articles by Jackson, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Arteriovenous Malformations
Hazardous Substances DB
*NITROGLYCERIN
*VERAPAMIL HYDROCHLORIDE

(Stroke. 1997;28:1115-1122.)
© 1997 American Heart Association, Inc.


Articles

Intra-arterial Nitrovasodilators Do Not Increase Cerebral Blood Flow in Angiographically Normal Territories of Arteriovenous Malformation Patients

Shailendra Joshi, MD; William L. Young, MD; John Pile-Spellman, MD; Patricia Fogarty-Mack, MD; Robert R. Sciacca, EngScD; Lotfi Hacein-Bey, MD; Hoang Duong, MD; Yvonne Vulliemoz, PhD; Noeleen Ostapkovich, REEG/EPT; Tara Jackson, BS

From the Departments of Anesthesiology (S.J., W.L.Y., P.F.-M., Y.V., N.O., T.J.), Neurological Surgery (W.L.Y., J.P.-S.), Radiology (W.L.Y., J.P.-S., L.H.-B., H.D.), Medicine (R.R.S.), and Pharmacology (Y.V.), College of Physicians and Surgeons, Columbia University, New York.

Correspondence to William L. Young, MD, P&S Box 46, Columbia University, College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032. E-mail WLY1{at}columbia.edu

Background and Purpose The mechanism of adaptation to chronic cerebral hypotension in normal brain adjacent to cerebral arteriovenous malformations (AVMs) is unknown. To clarify these mechanisms, we performed cerebral blood flow (CBF) studies in structurally and functionally normal vascular territories during 53 distal cerebral angiographic procedures in 37 patients with AVMs.

Methods CBF was measured using the superselective intra-arterial 133Xe method before and after a 3-minute infusion of either verapamil (1 mg·min-1, n=23), acetylcholine (1.33 µg·kg-1·min-1, n=7), nitroprusside (0.5 µg·kg-1·min-1, n=16) or nitroglycerin (0.5 µg·kg-1·min-1, n=7).

Results Mean±SD systemic (76±13 mm Hg) and distal cerebral arterial (55±16 mm Hg; range, 20 to 97 mm Hg) pressures were not different among groups. Verapamil increased CBF (45±12 to 65±21 mL·100 g-1·min-1, P<.001). There was no effect of acetylcholine (no change [46±9 to 46±9 mL·100 g-1·min-1], NS) or nitroglycerin (36±14 to 36±13 mL·100 g-1·min-1, NS). Nitroprusside decreased CBF (40±12 to 31±11 mL·100 g-1·min-1, P<.001). The percent change in CBF after drug administration was proportional to cerebral arterial pressure for verapamil only (r=.57, P=.0051).

Conclusions When infused intra-arterially in clinically relevant doses in both hypotensive and normotensive normal vascular territories remote from an AVM nidus, calcium channel blockade caused vasodilation, but there was an absence of response to nitric oxide–mediated vasodilators. These data suggest that (1) the nitric oxide pathway probably is not involved in the adaptation to chronic cerebral hypotension in AVM patients and (2) if our findings in vessels remote from or contralateral to the AVM are applicable to vessels of patients with other forms of cerebrovascular disease, clinically relevant doses of intra-arterial nitrovasodilators may not be useful in the manipulation of cerebrovascular resistance.


Key Words: autoregulation • calcium channel blockers • cerebral blood flow • nitric oxide




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
R. Hartl, S. Joshi, S. Levine, M. Wang, and R. R. Sciacca
Pial Arterial Response to Topical Verapamil in Acute Closed Cranial Windows in Rabbits
Anesth. Analg., April 1, 2005; 100(4): 1140 - 1146.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Lavi, R. Egbarya, R. Lavi, and G. Jacob
Role of Nitric Oxide in the Regulation of Cerebral Blood Flow in Humans: Chemoregulation Versus Mechanoregulation
Circulation, April 15, 2003; 107(14): 1901 - 1905.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Schaller, J. Schramm, D. Haun, and B. Meyer
Patterns of Cortical Oxygen Saturation Changes During CO2 Reactivity Testing in the Vicinity of Cerebral Arteriovenous Malformations
Stroke, April 1, 2003; 34(4): 938 - 944.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
L. Feng, B.-F. Fitzsimmons, W. L. Young, M. F. Berman, E. Lin, B. D. L. Aagaard, H. Duong, and J. Pile-Spellman
Intraarterially Administered Verapamil as Adjunct Therapy for Cerebral Vasospasm: Safety and 2-Year Experience
AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1284 - 1290.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. Joshi, H. Duong, S. Mangla, M. Wang, A. D. Libow, S. J. Popilskis, N. D. Ostapkovich, T. S. Wang, W. L. Young, and J. Pile-Spellman
In Nonhuman Primates Intracarotid Adenosine, but Not Sodium Nitroprusside, Increases Cerebral Blood Flow
Anesth. Analg., February 1, 2002; 94(2): 393 - 399.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Meyer, C. Schaller, C. Frenkel, B. Ebeling, and J. Schramm
Distributions of Local Oxygen Saturation and Its Response to Changes of Mean Arterial Blood Pressure in the Cerebral Cortex Adjacent to Arteriovenous Malformations
Stroke, December 1, 1999; 30(12): 2623 - 2630.
[Abstract] [Full Text] [PDF]